Literature DB >> 21603993

Advantage of robotic needle placement on a prostate model in HDR brachytherapy.

Gerd Strassmann1, Peter Olbert, Axel Hegele, Detlev Richter, Emmanouil Fokas, Nina Timmesfeld, Rainer Hofmann, Rita Engenhart-Cabillic.   

Abstract

PURPOSE: To compare the accuracy of the robot-assisted needle positioning with that of the conventional template-guided method with the help of a prostate model in high dose rate (HDR) brachytherapy.
MATERIALS AND METHODS: A prostate model of fresh porcine abdomen and special polyvinylchloride (PVC) sheets was developed. To verify the model, deviations from 311 needle placements of real prostate implants were analyzed. Second, the accuracy of the template-guided positioning versus robot-assisted positioning was measured with 20 needle insertions in the model. For robot-assisted positioning, different velocities (2.7, 5.4, 9.8 mm/s) of needle insertion were investigated.
RESULTS: The average needle positioning accuracies of manual template guidance on the model closely resembled those of real patients (approximately 3 mm). The average needle positioning accuracy for the robot-assisted method on the prostate model was 1.8 ± 0.6 mm, at a velocity of 2.7 mm/s and, in comparison to the template-guided method (2.7 ± 0.7 mm), was statistically more precise (p < 0.001). At higher robotic velocities, the measured needle positioning accuracy showed no significant difference from that of the manual insertion procedure.
CONCLUSION: By employing a prostate model, we showed for the first time that robot-assisted needle placement for HDR brachy-therapy is significantly more precise than the conventional method at a velocity of 2.7 mm/s. The robot-assisted needle positioning technique improves the degree of freedom by providing additional oblique insertion channels and could be potentially exploited not only for LDR but also for HDR brachytherapy.

Entities:  

Mesh:

Year:  2011        PMID: 21603993     DOI: 10.1007/s00066-011-2185-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  27 in total

1.  MRI-guided prostate brachytherapy with single needle method--a planning study.

Authors:  Marion P R Van Gellekom; Marinus A Moerland; Jan J Battermann; Jan J W Lagendijk
Journal:  Radiother Oncol       Date:  2004-06       Impact factor: 6.280

2.  Brachytherapy needle deflection evaluation and correction.

Authors:  Gang Wan; Zhouping Wei; Lori Gardi; Donal B Downey; Aaron Fenster
Journal:  Med Phys       Date:  2005-04       Impact factor: 4.071

3.  A new robotic needle insertion method to minimise attendant prostate motion.

Authors:  Vera Lagerburg; Marinus A Moerland; Marco van Vulpen; Jan J W Lagendijk
Journal:  Radiother Oncol       Date:  2006-07-25       Impact factor: 6.280

4.  Trajectory generation for robotic needle insertion in soft tissue.

Authors:  Niki Abolhassani; Rajni Patel; Mehrdad Moallem
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2004

5.  Robot-assisted prostate brachytherapy.

Authors:  Yan Yu; Tarun Podder; Yongde Zhang; Wan-Sing Ng; Vladimir Misic; Jason Sherman; Luke Fu; Dave Fuller; Edward Messing; Deborah Rubens; John Strang; Ralph Brasacchio
Journal:  Med Image Comput Comput Assist Interv       Date:  2006

6.  Dosimetric equivalence of nonstandard HDR brachytherapy catheter patterns.

Authors:  J A M Cunha; I C Hsu; J Pouliot
Journal:  Med Phys       Date:  2009-01       Impact factor: 4.071

7.  Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer.

Authors:  G Kovács; R Galalae; T Loch; H Bertermann; P Kohr; R Schneider; B Kimming
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

8.  [Combined treatment of localized prostate cancer with HDR-Iridium 192 remote brachytherapy and external beam irradiation].

Authors:  D Andreopoulos; M Piatkowiak; B Krenkel; U M Schleicher; J M Wolff
Journal:  Strahlenther Onkol       Date:  1999-08       Impact factor: 3.621

9.  3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.

Authors:  Thomas Martin; Dimos Baltas; Ralf Kurek; Sandra Röddiger; Marina Kontova; Georgios Anagnostopoulos; Thomas Dannenberg; Thomas Buhleier; Georgies Skazikis; Ulf Tunn; Nikolaos Zamboglou
Journal:  Strahlenther Onkol       Date:  2004-04       Impact factor: 3.621

10.  Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer.

Authors:  Pirus Ghadjar; Nicole Gwerder; Axel Madlung; Frank Behrensmeier; George N Thalmann; Roberto Mini; Daniel M Aebersold
Journal:  Strahlenther Onkol       Date:  2009-11-10       Impact factor: 3.621

View more
  3 in total

1.  Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer.

Authors:  A Singer; Y Deuse; U Koch; T Hölscher; D Pfitzmann; C Jakob; S Hehlgans; G B Baretton; A Rentsch; M Baumann; M H Muders; M Krause
Journal:  Strahlenther Onkol       Date:  2012-11-07       Impact factor: 3.621

2.  Axially rigid steerable needle with compliant active tip control.

Authors:  M de Vries; J Sikorski; S Misra; J J van den Dobbelsteen
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

3.  Re-implantation after insufficient primary 125-i permanent prostate brachytherapy.

Authors:  Paul Martin Putora; Ludwig Plasswilm; Wolf Seelentag; Johann Schiefer; Patrick Markart; Hans-Peter Schmid; Daniel Engeler
Journal:  Radiat Oncol       Date:  2013-08-06       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.